Filtros de búsqueda

Lista de obras de Tanios Bekaii-Saab

A Cancer and Leukemia Group B phase II study of sunitinib malate in patients with previously treated metastatic pancreatic adenocarcinoma (CALGB 80603).

artículo científico publicado en 2010

A Comprehensive Review of Sequencing and Combination Strategies of Targeted Agents in Metastatic Colorectal Cancer

artículo científico publicado en 2017

A Dose Escalation and Pharmacodynamic Study of Triapine and Radiation in Patients With Locally Advanced Pancreas Cancer ⬇️

artículo científico publicado el 17 de julio de 2012

A Multicenter Phase II Study of Gemcitabine, Capecitabine, and Bevacizumab for Locally Advanced or Metastatic Biliary Tract Cancer

artículo científico publicado en 2016

A Multicenter, Open-Label Phase II Clinical Trial of Combined MEK plus EGFR Inhibition for Chemotherapy-Refractory Advanced Pancreatic Adenocarcinoma

artículo científico publicado en 2015

A Phase I Trial of Interleukin-12 With Trastuzumab and Paclitaxel for HER2-Overexpressing Malignancies

A RAND/UCLA Appropriateness Study of the Management of Familial Gastric Cancer ⬇️

artículo científico publicado el 1 de septiembre de 2012

A Rare EGFR-SEPT14 Fusion in a Patient with Colorectal Adenocarcinoma Responding to Erlotinib

scientific article published on 22 October 2019

A SEER-based multi-ethnic picture of advanced intrahepatic cholangiocarcinoma in the United States pre- and post-the advent of gemcitabine/cisplatin

A Systematic Review and Network Meta-Analysis of Regorafenib and TAS-102 in Refractory Metastatic Colorectal Cancer ⬇️

scientific article published on 04 June 2019

A clinical trial protocol paper discussing the BRIGHTER study

artículo científico publicado en 2018

A closer look at regorafenib

scientific article published on 01 October 2018

A dose-finding and pharmacodynamic study of bortezomib in combination with weekly paclitaxel in patients with advanced solid tumors

artículo científico publicado en 2009

A dose-finding, pharmacokinetic and pharmacodynamic study of a novel schedule of flavopiridol in patients with advanced solid tumors ⬇️

artículo científico publicado el 12 de octubre de 2010

A modified regimen of biweekly gemcitabine and nab-paclitaxel in patients with metastatic pancreatic cancer is both tolerable and effective: a retrospective analysis

artículo científico publicado en 2016

A multi-institutional phase 2 study of neoadjuvant gemcitabine and oxaliplatin with radiation therapy in patients with pancreatic cancer

artículo científico publicado en 2013

A multi-institutional phase II study of the efficacy and tolerability of lapatinib in patients with advanced hepatocellular carcinomas

artículo científico publicado en 2009

A novel mutation in the tyrosine kinase domain of ERBB2 in hepatocellular carcinoma

artículo científico publicado en 2006

A phase I dose escalation and pharmacodynamic study of SU5416 (semaxanib) combined with weekly cisplatin and irinotecan in patients with advanced solid tumors

artículo científico publicado en 2013

A phase I dose escalation study of a pharmacobiologically based scheduling of capecitabine and mitomycin C in patients with gastrointestinal malignancies

artículo científico publicado en 2009

A phase I study of prolonged infusion of triapine in combination with fixed dose rate gemcitabine in patients with advanced solid tumors ⬇️

artículo científico publicado el 31 de julio de 2012

A phase I study of the biomodulation of capecitabine by docetaxel and gemcitabine (mGTX) in previously untreated patients with metastatic adenocarcinoma of the pancreas

artículo científico publicado en 2010

A phase I study of topotecan and gemcitabine in advanced solid tumors

artículo científico publicado en 2010

A phase II study of biweekly pralatrexate and docetaxel in patients with advanced esophageal and gastroesophageal carcinoma that have failed first-line platinum-based therapy

artículo científico publicado en 2015

A phase II study of modulated-capecitabine and docetaxel in chemonaive patients with advanced non-small cell lung cancer (NSCLC) ⬇️

artículo científico publicado el 16 de octubre de 2012

A treatment landscape in evolution: new strategies, guidelines, and therapeutic advances for metastatic pancreatic adenocarcinoma

artículo científico publicado en 2018

AB051. P-19. A phase II study of infigratinib (BGJ398) in previously-treated advanced cholangiocarcinoma containing FGFR2 fusions

AJCC 8th edition staging system for pathologically versus clinically staged intrahepatic cholangiocarcinoma (iCCA): ready for prime time?

scientific article published on 06 May 2019

Adjuvant Therapy for Resected Biliary Tract Cancer: ASCO Clinical Practice Guideline

artículo científico publicado en 2019

Adjuvant therapy for pancreas cancer in an era of value based cancer care

artículo científico publicado en 2016

Ampullary cancer: an overview

artículo científico publicado en 2014

An update on biochemotherapy of advanced gastric and gastroesophageal adenocarcinoma

artículo científico publicado en 2008

Anal Carcinoma, Version 2.2012: featured updates to the NCCN guidelines

artículo científico publicado en 2012

Anti-IL-6 and PD-L1 antibody combination therapy reduces tumor progression in murine models of pancreatic cancer.

artículo científico publicado en 2015

Anti-Tumor Effects of Peptide Therapeutic and Peptide Vaccine Antibody Co-targeting HER-1 and HER-2 in Esophageal Cancer (EC) and HER-1 and IGF-1R in Triple-Negative Breast Cancer (TNBC).

artículo científico publicado en 2015

Antiangiogenic Therapy in Colorectal Cancer

scientific article published on 01 July 2018

Antiemetic control with palonosetron in patients with gastrointestinal cancer receiving a fluoropyrimidine-based regimen in addition to either irinotecan or oxaliplatin: a retrospective study

artículo científico publicado en 2012

Appendiceal Mixed Adeno-Neuroendocrine Carcinoma: A Population-Based Study of the Surveillance, Epidemiology, and End Results Registry

artículo científico publicado en 2016

Appendiceal Mucinous Neoplasms: Diagnosis and Management

artículo científico publicado en 2017

Appendiceal Mucinous Neoplasms: Diagnosis and Management

artículo científico publicado en 2018

Appendiceal Neuroendocrine, Goblet and Signet-Ring Cell Tumors: A Spectrum of Diseases with Different Patterns of Presentation and Outcome

artículo científico publicado en 2015

Application of next-generation sequencing in gastrointestinal and liver tumors

artículo científico publicado en 2016

Autophagy Induction Results in Enhanced Anoikis Resistance in Models of Peritoneal Disease

artículo científico publicado en 2016

BMS-911543 inhibits viability of tumor and stromal cells and limits disease progression in genetically engineered mice with pancreatic cancer

artículo científico publicado en 2014

Baseline serum albumin is a predictive biomarker for patients with advanced pancreatic cancer treated with bevacizumab: a pooled analysis of 7 prospective trials of gemcitabine-based therapy with or without bevacizumab

artículo científico publicado en 2014

Biliary cancer: Utility of next-generation sequencing for clinical management

artículo científico publicado en 2016

Biliary cancer: intrahepatic cholangiocarcinoma vs. extrahepatic cholangiocarcinoma vs. gallbladder cancers: classification and therapeutic implications

artículo científico publicado en 2017

Biliary tract cancer and genomic alterations in homologous recombinant deficiency: exploiting synthetic lethality with PARP inhibitors

artículo científico publicado en 2020

Biomodulation of capecitabine by paclitaxel and carboplatin in advanced solid tumors and adenocarcinoma of unknown primary

artículo científico publicado en 2015

Biweekly cisplatin and gemcitabine in patients with advanced biliary tract cancer.

artículo científico publicado en 2017

Biweekly gemcitabine and low-dose cisplatin in the treatment of locally advanced or metastatic pancreatic cancer patients: a single institute experience

artículo científico publicado en 2015

CanStem111P trial: a Phase III study of napabucasin plus nab-paclitaxel with gemcitabine

scientific article published on 15 February 2019

Capped-dose mitomycin C: a pooled safety analysis from three prospective clinical trials

artículo científico publicado en 2010

Carbohydrate antigen 19-9 is a prognostic and predictive biomarker in patients with advanced pancreatic cancer who receive gemcitabine-containing chemotherapy: a pooled analysis of 6 prospective trials

artículo científico publicado en 2012

Caveolin-1 is Associated with Tumor Progression and Confers a Multi-Modality Resistance Phenotype in Pancreatic Cancer

artículo científico publicado en 2015

Cholangiocarcinoma cells secrete soluble factors that activate Jak/STAT signal transduction and promote MDSC expansion

artículo científico publicado en 2014

Circulating interleukin-6 is associated with disease progression, but not cachexia in pancreatic cancer

scientific article published on 10 November 2018

Clinical Trial Data for Third-Line Therapy in Metastatic Colorectal Cancer

scientific article published on 01 March 2019

Clinical Trials and Progress in Metastatic Colon Cancer

artículo científico publicado en 2018

Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study

artículo científico publicado en 2020

Clinical update on K-Ras targeted therapy in gastrointestinal cancers

artículo científico publicado en 2018

Colon cancer

artículo científico publicado en 2011

Colon cancer, version 3.2014.

artículo científico publicado en 2014

Competitive Funding Strategies for the Conquer Cancer Foundation of ASCO.

artículo científico publicado en 2016

Complete clinical response of metastatic hepatocellular carcinoma to sorafenib in a patient with hemochromatosis: a case report

artículo científico publicado en 2008

Comprehensive Genomic Profiling of Advanced Esophageal Squamous Cell Carcinomas and Esophageal Adenocarcinomas Reveals Similarities and Differences

artículo científico publicado en 2015

Comprehensive population-wide analysis of Lynch syndrome in Iceland reveals founder mutations in MSH6 and PMS2.

artículo científico publicado en 2017

Cost description of chemotherapy regimens for the treatment of metastatic pancreas cancer.

artículo científico publicado en 2016

CpG Island Methylation, Microsatellite Instability, and BRAF Mutations and Their Clinical Application in the Treatment of Colon Cancer.

artículo científico publicado en 2012

Curcumin analogues exhibit enhanced growth suppressive activity in human pancreatic cancer cells

artículo científico publicado en 2009

Defining surgical quality in gastric cancer: a RAND/UCLA appropriateness study

artículo científico

Development and Validation of a Nomogram for Early Detection of Malignant Gallbladder Lesions

scientific article published on 01 October 2019

Distinct myeloid suppressor cell subsets correlate with plasma IL-6 and IL-10 and reduced interferon-alpha signaling in CD4+ T cells from patients with GI malignancy ⬇️

artículo científico publicado el 21 de mayo de 2011

Does Delaying Surgical Resection After Neoadjuvant Chemoradiation Impact Clinical Outcomes in Locally Advanced Rectal Adenocarcinoma?: A Single-Institution Experience

artículo científico publicado en 2015

Early dose reduction/delay and the efficacy of liposomal irinotecan with fluorouracil and leucovorin in metastatic pancreatic ductal adenocarcinoma (mPDAC): A post hoc analysis of NAPOLI-1

artículo científico publicado en 2020

Elevated baseline CA19-9 levels correlate with adverse prognosis in patients with early- or advanced-stage pancreas cancer

scientific article published on 24 June 2012

Emerging Therapies and Future Directions in Targeting the Tumor Stroma and Immune System in the Treatment of Pancreatic Adenocarcinoma

artículo científico publicado en 2018

Emerging Treatments in Recurrent and Metastatic Colorectal Cancer ⬇️

artículo científico publicado el 1 de septiembre de 2013

Esophageal Cancer Clinical Practice Guidelines

scientific article published on 01 April 2006

Esophageal cancer

artículo científico publicado en 2008

Expanding the arsenal for metastatic colorectal cancer: a discussion of current clinical trials

artículo científico publicado en 2009

FIGHT-302: first-line pemigatinib vs gemcitabine plus cisplatin for advanced cholangiocarcinoma with FGFR2 rearrangements

artículo científico publicado en 2020

FOLFIRINOX in Locally Advanced Pancreas Adenocarcinoma: Back to the Future? ⬇️

artículo científico publicado el 1 de enero de 2013

Fractionated radioimmunotherapy with 90Y‐clivatuzumab tetraxetan and low‐dose gemcitabine is active in advanced pancreatic cancer ⬇️

artículo científico publicado el 8 de mayo de 2012

Gastric Cancer Clinical Practice Guidelines

scientific article published on 01 April 2006

Gastric cancer

artículo científico publicado en 2010

Gemcitabine-Associated Thrombotic Microangiopathy: Response to Complement Inhibition and Reinitiation of Gemcitabine

scientific article published on 20 September 2016

Gene-mediated cytotoxic immunotherapy as adjuvant to surgery or chemoradiation for pancreatic adenocarcinoma

artículo científico publicado en 2015

Genetically engineered murine pancreatic cancer models approximate immunophenotypic properties of human patients

artículo científico publicado en 2013

Genomic diversity of colorectal cancer: Changing landscape and emerging targets

artículo científico publicado en 2016

Genomic profiling reveals high frequency of DNA repair genetic aberrations in gallbladder cancer

artículo científico publicado en 2020

HER2/neu May Not Be an Interesting Target in Biliary Cancers: Results of an Early Phase II Study with Lapatinib ⬇️

artículo científico publicado el 15 de marzo de 2012

Hepatobiliary cancers. Clinical practice guidelines in oncology

artículo científico publicado en 2006

Highlights in pancreatic cancer from the 2018 American Society of Clinical Oncology Gastrointestinal Cancers Symposium: commentary

artículo científico publicado en 2018

Homologous Recombination Repair Defect May Predict Treatment Response to Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors

artículo científico publicado en 2020

How I treat metastatic colorectal cancer

scientific article published on 01 September 2018

IL-21 Enhances Natural Killer Cell Response to Cetuximab-Coated Pancreatic Tumor Cells

artículo científico publicado en 2016

IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancer

artículo científico publicado en 2016

Identifying and targeting cancer stem cells in the treatment of gastric cancer

artículo científico publicado en 2017

Immunogenicity and antitumor efficacy of a novel human PD-1 B-cell vaccine (PD1-Vaxx) and combination immunotherapy with dual trastuzumab/pertuzumab-like HER-2 B-cell epitope vaccines (B-Vaxx) in a syngeneic mouse model

scientific article published on 01 October 2020

Immunological predictors of overall survival in treatment naïve metastatic pancreatic cancer patients.

artículo científico publicado en 2015

Improvements in Clinical Outcomes for BRAFV600E-mutant Metastatic Colorectal Cancer

scientific article published on 06 April 2020

Incidence and Survival of Appendiceal Mucinous Neoplasms: A SEER Analysis

artículo científico publicado en 2015

Incidence of minimally invasive colorectal cancer surgery at National Comprehensive Cancer Network centers

artículo científico publicado en 2014

Incorporation of photodynamic therapy as an induction modality in non-small cell lung cancer

artículo científico publicado en 2006

Infigratinib (BGJ398): An investigational agent for the treatment of FGFR-altered intrahepatic cholangiocarcinoma

scientific article published on 12 December 2020

Influence of KRAS mutation status in metachronous and synchronous metastatic colorectal adenocarcinoma ⬇️

artículo científico publicado el 6 de junio de 2012

Integrating anti-EGFR therapies in metastatic colorectal cancer

artículo científico publicado en 2013

Interactions of tamoxifen, N-desmethyltamoxifen and 4-hydroxytamoxifen with P-glycoprotein and CYP3A.

artículo científico publicado en 2004

KRAS testing in metastatic colorectal cancer: implications on the use of biologic agents

artículo científico publicado en 2009

Landmark survival analysis and impact of anatomic origin in prospective clinical trials of biliary tract cancer

scientific article published on 21 May 2020

Lipocalin-2 Promotes Pancreatic Ductal Adenocarcinoma by Regulating Inflammation in the Tumor Microenvironment

artículo científico publicado en 2017

Localized colon cancer, version 3.2013: featured updates to the NCCN Guidelines

artículo científico publicado en 2013

Maintenance therapy for colorectal cancer: which regimen and which patients?

artículo científico

Management of Venous Thromboembolism in Patients with Advanced Gastrointestinal Cancers: What Is the Role of Novel Oral Anticoagulants? ⬇️

artículo científico publicado el 11 de septiembre de 2012

Metastatic colon cancer, version 3.2013: featured updates to the NCCN Guidelines

artículo científico

MicroRNA profiling of patient plasma for clinical trials using bioinformatics and biostatistical approaches

artículo científico publicado en 2016

Mixed Adeno-neuroendocrine Carcinoma: An Aggressive Clinical Entity

artículo científico publicado en 2016

Moving forward with expanding to an "all-RAS mutational analysis" in metastatic colorectal cancer: beyond KRAS mutations

artículo científico publicado en 2014

Multi-Institutional Phase II Study of Selumetinib in Patients With Metastatic Biliary Cancers ⬇️

artículo científico publicado el 25 de abril de 2011

Multi-drug inhibition of the HER pathway in metastatic colorectal cancer: Results of a phase I study of pertuzumab plus cetuximab in cetuximab-refractory patients ⬇️

artículo científico publicado el 9 de abril de 2013

Mutant KRAS promotes liver metastasis of colorectal cancer, in part, by upregulating the MEK-Sp1-DNMT1-miR-137-YB-1-IGF-IR signaling pathway

artículo científico publicado en 2018

Neoadjuvant FOLFIRINOX in Patients With Borderline Resectable Pancreatic Cancer: A Systematic Review and Patient-Level Meta-Analysis

scientific article published on 01 August 2019

Neoadjuvant Therapy for Rectal Cancer Affects Lymph Node Yield and Status Without Clear Implications on Outcome: The Case for Eliminating a Metric and Using Preoperative Staging to Guide Therapy

artículo científico publicado en 2016

Neoadjuvant modified (m) FOLFIRINOX for locally advanced unresectable (LAPC) and borderline resectable (BRPC) adenocarcinoma of the pancreas

artículo científico publicado en 2014

Neoadjuvant radiotherapy use in locally advanced rectal cancer at NCCN member institutions

artículo científico publicado en 2014

New guideline-sanctioned and emerging interventions for pancreatic cancer

scientific article published on 01 September 2018

Next-generation sequencing survey of biliary tract cancer reveals the association between tumor somatic variants and chemotherapy resistance

artículo científico publicado en 2016

Nivolumab for previously treated unresectable metastatic anal cancer (NCI9673): a multicentre, single-arm, phase 2 study

artículo científico

Nomogram for Predicting Survival in Patients Treated with Liposomal Irinotecan Plus Fluorouracil and Leucovorin in Metastatic Pancreatic Cancer

artículo científico publicado en 2019

Optimal management of gastric cancer: results from an international RAND/UCLA expert panel.

artículo científico publicado en 2014

Optimizing Neoadjuvant Therapy for Rectal Cancer With Oxaliplatin ⬇️

artículo científico publicado el 1 de marzo de 2013

Outcomes in patients with obstructive jaundice from metastatic colorectal cancer and implications for management

artículo científico publicado en 2014

Outcomes of definitive chemoradiation in patients with esophageal cancer

artículo científico publicado en 2016

Overcoming resistance to anabolic SARM therapy in experimental cancer cachexia with an HDAC inhibitor

artículo científico publicado en 2020

Pain, depression, and fatigue: loneliness as a longitudinal risk factor

artículo científico publicado en 2013

Pancreatic cancer-associated stellate cells promote differentiation of myeloid-derived suppressor cells in a STAT3-dependent manner

artículo científico publicado en 2013

Patients with colorectal cancer associated with Lynch syndrome and MLH1 promoter hypermethylation have similar prognoses

artículo científico publicado en 2016

Patients with pancreatic adenocarcinoma exhibit elevated levels of myeloid-derived suppressor cells upon progression of disease

artículo científico publicado en 2014

Peptide Vaccines and Peptidomimetics of EGFR (HER-1) Ligand Binding Domain Inhibit Cancer Cell Growth In Vitro and In Vivo ⬇️

artículo científico publicado el 22 de mayo de 2013

Perineural Invasion Predicts for Distant Metastasis in Locally Advanced Rectal Cancer Treated With Neoadjuvant Chemoradiation and Surgery

artículo científico publicado en 2015

Perspectives on immunotherapy utilization for hepatobiliary cancers in the United States

artículo científico publicado en 2020

Phase 1 Study of CEP-37250/KHK2804, a Tumor-specific Anti-glycoconjugate Monoclonal Antibody, in Patients with Advanced Solid Tumors

artículo científico publicado en 2016

Phase 1 trial of Vismodegib and Erlotinib combination in metastatic pancreatic cancer

scientific article published on 21 November 2019

Phase I Immunotherapy Trial with Two Chimeric HER-2 B-Cell Peptide Vaccines Emulsified in Montanide ISA 720VG and Nor-MDP Adjuvant in Patients with Advanced Solid Tumors

scientific article published on 25 February 2019

Phase I Study of AMG 337, a Highly Selective Small-molecule MET Inhibitor, in Patients with Advanced Solid Tumors

artículo científico publicado en 2018

Phase I Trial of Trametinib with Neoadjuvant Chemoradiation in Patients with Locally Advanced Rectal Cancer

scientific article published on 06 April 2020

Phase I dose-escalation study of EZN-2208 (PEG-SN38), a novel conjugate of poly(ethylene) glycol and SN38, administered weekly in patients with advanced cancer

scientific article published on 30 March 2013

Phase I trial of non-cytotoxic suramin as a modulator of docetaxel and gemcitabine therapy in previously treated patients with non-small cell lung cancer

artículo científico publicado en 2010

Phase II Study of BGJ398 in Patients With FGFR-Altered Advanced Cholangiocarcinoma.

artículo científico publicado en 2017

Phase II randomized study of two regimens of sequentially administered mitomycin C and irinotecan in patients with unresectable esophageal and gastroesophageal adenocarcinoma

artículo científico publicado en 2010

Phase II trial of pyrazoloacridine (NSC#366140) in patients with metastatic breast cancer

artículo científico publicado en 2009

Photodynamic therapy (PDT) may provide effective palliation in the treatment of primary tracheal carcinoma: a small case series

artículo científico publicado en 2012

Practical considerations in the use of regorafenib in metastatic colorectal cancer

artículo científico publicado en 2020

Preclinical Investigation of the Novel Histone Deacetylase Inhibitor AR-42 in the Treatment of Cancer-Induced Cachexia

artículo científico publicado en 2015

Predictors of Pancreatic Cancer-Associated Weight Loss and Nutritional Interventions

artículo científico publicado en 2017

Preoperative Modified FOLFIRINOX Treatment Followed by Capecitabine-Based Chemoradiation for Borderline Resectable Pancreatic Cancer: Alliance for Clinical Trials in Oncology Trial A021101.

artículo científico publicado en 2016

Processes of care in the multidisciplinary treatment of gastric cancer: results of a RAND/UCLA expert panel

artículo científico publicado en 2014

Prostate cancer incidence in males with Lynch syndrome

artículo científico publicado en 2014

Randomised phase II trial of gemcitabine and nab-paclitaxel with necuparanib or placebo in untreated metastatic pancreas ductal adenocarcinoma

artículo científico publicado en 2020

Real-World Dosing Patterns and Outcomes of Patients With Metastatic Pancreatic Cancer Treated With a Liposomal Irinotecan Regimen in the United States

artículo científico publicado en 2020

Rectal Cancer, Version 2.2015.

artículo científico

Rectal cancer

artículo científico publicado en 2012

Recurrent life-threatening deep tissue hematomas after switching to generic enoxaparin: a report and perspective on the approval process for biological compounds

artículo científico publicado en 2011

Response to Drs Von Hoff and Renschler

artículo científico publicado en 2017

Results of an abbreviated phase-II study with the Akt Inhibitor MK-2206 in Patients with Advanced Biliary Cancer

artículo científico publicado en 2015

Retraction: Targeting the Warburg effect with a novel glucose transporter inhibitor to overcome gemcitabine resistance in pancreatic cancer cells

scientific article published on 01 April 2019

STAT3 signaling pathway is necessary for cell survival and tumorsphere forming capacity in ALDH+/CD133+ stem cell-like human colon cancer cells ⬇️

artículo científico publicado el 31 de octubre de 2011

Second-line outcomes in metastatic colorectal cancer--raising the bar for the high jump rather than the doing the limbo

artículo científico publicado en 2014

Second-line treatment in patients with pancreatic ductal adenocarcinoma: A meta-analysis.

artículo científico publicado en 2017

Seeing the forest through the trees: a systematic review of the safety and efficacy of combination chemotherapies used in the treatment of metastatic colorectal cancer

artículo científico

Selumetinib for the treatment of cancer

artículo científico publicado en 2014

Sequencing beyond the second-line setting in metastatic colorectal cancer

scientific article published on 01 March 2019

Sequencing beyond the second-line setting in metastatic colorectal cancer: further observations

artículo científico publicado en 2019

Should combination chemotherapy serve as the backbone in clinical trials of advanced pancreatic cancer? A pooled analysis of phase II trials of gemcitabine-containing doublets plus bevacizumab

artículo científico publicado en 2014

Signaling pathways as therapeutic targets in biliary tract cancer.

artículo científico publicado en 2017

Single agent BMS-911543 Jak2 inhibitor has distinct inhibitory effects on STAT5 signaling in genetically engineered mice with pancreatic cancer

artículo científico publicado en 2015

Spotlight on bevacizumab in metastatic colorectal cancer: patient selection and perspectives

artículo científico publicado en 2016

Successful Completion of Adjuvant Chemotherapy in a Patient With Colon Cancer Experiencing 5-Fluorouracil-Induced Cardiac Vasospasm

artículo científico publicado en 2015

Suppression of Tumor Growth and Muscle Wasting in a Transgenic Mouse Model of Pancreatic Cancer by the Novel Histone Deacetylase Inhibitor AR-42.

artículo científico publicado en 2016

Suppressive myeloid cells are expanded by biliary tract cancer-derived cytokines in vitro and associate with aggressive disease

artículo científico publicado en 2020

Systemic Immune Activity Predicts Overall Survival in Treatment-Naïve Patients with Metastatic Pancreatic Cancer

artículo científico publicado en 2015

Systemic Therapy and Sequencing Options in Advanced Hepatocellular Carcinoma: A Systematic Review and Network Meta-analysis

scientific article published on 22 October 2020

Systemic therapy for advanced appendiceal adenocarcinoma: an analysis from the NCCN Oncology Outcomes Database for colorectal cancer

artículo científico publicado en 2014

Systemic therapy in younger and elderly patients with advanced biliary cancer: sub-analysis of ABC-02 and twelve other prospective trials

artículo científico publicado en 2017

Taking aim at the genomic diversity of gastrointestinal cancers: a changing landscape

artículo científico publicado en 2016

Targeting BRAF in metastatic colorectal cancer: Maximizing molecular approaches.

artículo científico publicado en 2017

Targeting integrin-linked kinase to suppress oncogenic KRAS signaling in pancreatic cancer.

artículo científico publicado en 2016

Targeting of the Hedgehog/GLI and mTOR pathways in advanced pancreatic cancer, a phase 1 trial of Vismodegib and Sirolimus combination

scientific article published on 14 July 2020

Targeting the Warburg effect with a novel glucose transporter inhibitor to overcome gemcitabine resistance in pancreatic cancer cells

artículo científico publicado en 2014

The Continued Promise and Many Disappointments of Oncolytic Virotherapy in Gastrointestinal Malignancies

artículo científico publicado en 2017

The Efficacy of Adjuvant Chemotherapy in Patients With Stage II/III Resected Rectal Cancer Treated With Neoadjuvant Chemoradiation Therapy

artículo científico publicado en 2015

The Role of Maintenance Strategies in Metastatic Colorectal Cancer: A Systematic Review and Network Meta-analysis of Randomized Clinical Trials

artículo científico publicado en 2019

The Role of Maintenance Therapy in Metastatic Colorectal Cancer-Reply

artículo científico publicado en 2020

The addition of radiation to chemotherapy does not improve outcome when compared to chemotherapy in the treatment of resected pancreas cancer: the results of a single-institution experience

artículo científico publicado en 2013

Therapeutic Targeting Strategies of Cancer Stem Cells in Gastrointestinal Malignancies

artículo científico publicado en 2019

Therapeutic advances in metastatic pancreatic adenocarcinoma and related cancers: focus on evidence-based and sequenced approaches to survival extension in metastatic pancreatic adenocarcinoma

scientific article published on 01 September 2018

Therapeutic advances in pancreatic cancer: miles to go before we sleep

artículo científico publicado en 2015

Therapeutic options for intrahepatic cholangiocarcinoma

artículo científico publicado en 2017

Third- or Later-line Therapy for Metastatic Colorectal Cancer: Reviewing Best Practice

artículo científico publicado en 2018

Treatment-related Hypertension as a Pharmacodynamic Biomarker for the Efficacy of Bevacizumab in Advanced Pancreas Cancer: A Pooled Analysis of 4 Prospective Trials of Gemcitabine-based Therapy With Bevacizumab

artículo científico publicado en 2014

Trends in intensity modulated radiation therapy use for locally advanced rectal cancer at National Comprehensive Cancer Network centers

artículo científico publicado en 2017

UDP-glucuronosyltransferase (UGT) 2B15 pharmacogenetics: UGT2B15 D85Y genotype and gender are major determinants of oxazepam glucuronidation by human liver

artículo científico publicado en 2004

Upfront molecular testing in patients with advanced gastro-esophageal cancer: Is it time yet?

artículo científico publicado en 2015

Using Naïve Bayesian Analysis to Determine Imaging Characteristics of KRAS Mutations in Metastatic Colon Cancer

artículo científico publicado en 2017

Veliparib Alone or in Combination with Mitomycin C in Patients with Solid Tumors With Functional Deficiency in Homologous Recombination Repair

artículo científico publicado en 2016

Watch and Wait in Rectal Cancer: Who's In and Who's Out?

scientific article published on 01 March 2019

What provider volumes and characteristics are appropriate for gastric cancer resection? Results of an international RAND/UCLA expert panel ⬇️

artículo científico publicado el 26 de septiembre de 2013

Whole-exome tumor sequencing study in biliary cancer patients with a response to MEK inhibitors

artículo científico publicado en 2015

Yttrium-90 Radioembolization as Salvage Therapy for Colorectal Cancer With Liver Metastases ⬇️

artículo científico publicado el 24 de enero de 2012

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda